Ignite Creation Date:
2024-05-06 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 1:55 PM
Study NCT ID:
NCT04731909
Status:
UNKNOWN
Last Update Posted:
2021-02-10
First Post:
2021-01-27
Brief Title:
Toripalimab Combined With Anlotinib Etoposide and Platinum in the Treatment of Extensive-stage Small Cell Lung Cancer
Sponsor:
Third Military Medical University
Organization:
Third Military Medical University
Organization Data
Organization:
Third Military Medical University
Class:
OTHER
Study ID:
ALT-SCLC-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Third Military Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
Dong Wang
Responsible Party Title:
Head of Oncology
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Third Military Medical University
Old Name:
None
Old Organization:
None